Childrens Nasacort Allergy 24HR

Manufacturer
Chattem, Inc.
Effective date
2015-07-01
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
legacy-cache
Hydrated at
2026-08-01 23:16:49

Label at a glance#

ProductChildrens Nasacort Allergy 24HR
Active ingredientTRIAMCINOLONE ACETONIDE
Label structure11 sections

Indications and uses

temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion   runny nose   sneezing   itchy nose

Dosage and administration

Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for more than 2 weeks use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day CH...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each spray) 

Triamcinolone acetonide 

55 mcg (glucocorticoid)

Purpose

OTC - PURPOSE SECTION

Allergy symptom reliever

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms of hay fever or other upper respiratory allergies:

  • nasal congestion  
  • runny nose  
  • sneezing  
  • itchy nose

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

  • in children under 2 years of age
  • if you have ever had an allergic reaction to any of the ingredients

Ask a doctor before use if you

OTC - ASK DOCTOR SECTION

  • have had recent nose ulcers or nose surgery
  • have had a nose injury that has not healed
  • are using a steroid medicine for asthma, allergies or skin rash
  • have an eye infection
  • have or had glaucoma or cataracts

When using this product

OTC - WHEN USING SECTION

  • the growth rate of some children may be slower
  • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief.
  • do not share this bottle with anyone else as this may spread germs
  • remember to tell your doctor about all the medicines you take, including this one

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis
  • you have or develop symptoms of an infection such as a persistent fever
  • you have any change in vision
  • you have severe or frequent nosebleeds

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.  

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Read insert (inside package) on how to:

  • get a new bottle ready (primed) before first use
  • prime bottle again if not used for more than 2 weeks
  • use the spray
  • clean the spray nozzle
ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER
adults and children 12
years of age and older
  • once daily, spray 2 times into each nostril while sniffing gently
  • once your allergy symptoms improve, reduce to 1 spray in each nostril per day
CHILDREN 2 TO UNDER 12 YEARS OF AGE
  • the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year.
children 6 to under 12 years of age
  • an adult should supervise use
  • once daily, spray 1 time into each nostril while sniffing gently
  • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day.
children 2 to under 6 years of age
  • an adult should supervise use
  • once daily, spray 1 time into each nostril while sniffing gently
children under 2 years of age
  • do not use
  • do not use more than directed
  • if you forget a dose, do not double the next dose
  • do not spray into eyes or mouth
  • if allergy symptoms do not improve after one week, stop using and talk to a doctor
  • do not use for the common cold
  • shake well before each use

Other information

SPL UNCLASSIFIED SECTION

  • do not use if sealed package is torn or opened
  • keep package and insert. They contain important information.
  • store between 20°- 25°C (68°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, carboxymethylcellulose sodium, dextrose, edetate disodium, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water

Questions or comments?

OTC - QUESTIONS SECTION

call toll-free 1-800-633-1610

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Original Prescription Strength
NDC 41167-5900-2
Multi-Symptom
Nasal Allergy Spray
Children's
Nasacort Allergy 24HR

triamcinolone acetonide nasal spray 55 mcg per spray 
allergy symptom reliever

(glucocorticoid)*

60 Sprays

0.37 fl. oz. (10.8 ml)

*Triamcinolone acetonide

is a steroid medicine

known as a glucocorticoid.

Original Prescription Strength NDC 41167-5900-2 Multi-Symptom Nasal Allergy Spray Children's Nasacort Allergy 24HR triamcinolone acetonide nasal spray 55 mcg per spray allergy s...Original Prescription Strength NDC 41167-5900-2 Multi-Symptom Nasal Allergy Spray Children's Nasacort Allergy 24HR triamcinolone acetonide nasal spray 55 mcg per spray allergy s...

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Multi-Symptom
Nasal Allergy Spray

Triamcinolone acetonide nasal spray 55 mcg per spray

Allergy symptom reliever

(glucocorticoid)


Children's
Nasacort
Allergy 24HR Insert

Multi-Symptom Nasal Allergy Spray Triamcinolone acetonide nasal spray 55 mcg per spray Allergy symptom reliever (glucocorticoid) Children's Nasacort Allergy 24HR InsertMulti-Symptom Nasal Allergy Spray Triamcinolone acetonide nasal spray 55 mcg per spray Allergy symptom reliever (glucocorticoid) Children's Nasacort Allergy 24HR Insert

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
41167-5900-2ML - Milliliter41167-5900e5074a90-6824-414a-851e-cafda93d1dd312015-11-12

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TRIAMCINOLONE ACETONIDEACTIVE INGREDIENTF446C597KA2
TRIAMCINOLONE ACETONIDEACTIVE MOIETYF446C597KA2
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W72
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMINACTIVE INGREDIENTK679OBS3112
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
DEXTROSE, UNSPECIFIED FORMINACTIVE INGREDIENTIY9XDZ35W22
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K2
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB2
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8H2
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
41167-590041167-5900-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 594 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICAPSULE, COATED / ORAL0.08 mgExact identifier — unii candidate
174 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SPRAY / NASAL1 mgExact identifier — unii candidate
24 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS0.4 mgExact identifier — unii candidate
77 equally ranked IID candidates
DEXTROSE, UNSPECIFIED FORMDEXTROSEIY9XDZ35W2SOLUTION / ORAL2489 mg/5mlExact identifier — unii candidate
21 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311TABLET, DELAYED RELEASE / ORAL280 mgExact identifier — unii candidate
44 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61USUSPENSION, EXTENDED RELEASE / ORAL1120 mgExact identifier — unii candidate
28 equally ranked IID candidates
DEXTROSE, UNSPECIFIED FORMDEXTROSEIY9XDZ35W2CONCENTRATE / ORAL400 mgExact identifier — unii candidate
21 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPOWDER, FOR SOLUTION / ORAL690 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311INJECTION, SUSPENSION / INTRALESIONAL15 mgExact identifier — unii candidate
44 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, FOR SOLUTION / INTRADERMALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET / SUBLINGUAL0.08 mgExact identifier — unii candidate
78 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSUSPENSION/ DROPS / TOPICALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KPOWDER, FOR SUSPENSION / ORAL285 mgExact identifier — unii candidate
77 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IAEROSOL, FOAM / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / RECTALNAExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRAVENOUS4680 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL1576 mgExact identifier — unii candidate
28 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / RECTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION, SUSPENSION / SOFT TISSUEADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL / TOPICAL70 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, EFFERVESCENT / ORAL32 mgExact identifier — unii candidate
77 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION, SUSPENSION / INTRAVITREALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, SUSPENSION / INTRA-ARTICULAR1 mgExact identifier — unii candidate
77 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IDISC / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7INJECTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
24 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE / ORAL2169 mgExact identifier — unii candidate
28 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311TABLET, COATED / ORAL3.2 mgExact identifier — unii candidate
44 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRADERMALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBLIQUID / INTRAVENOUSADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET, COATED / ORALNAExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
78 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSUSPENSION/ DROPS / AURICULAR (OTIC)0.01 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
174 equally ranked IID candidates
DEXTROSE, UNSPECIFIED FORMDEXTROSEIY9XDZ35W2TABLET, DELAYED RELEASE / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRAVENOUS720 mgExact identifier — unii candidate
148 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / ORAL206 mgExact identifier — unii candidate
78 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7GEL / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSPRAY, METERED / NASAL4 mgExact identifier — unii candidate
77 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR25 mgExact identifier — unii candidate
44 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HOINTMENT / TOPICAL0.1 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL / OPHTHALMIC6 mgExact identifier — unii candidate
174 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311POWDER, FOR SUSPENSION / INTRAMUSCULAR0.7 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
DEXTROSE, UNSPECIFIED FORMDEXTROSEIY9XDZ35W2PASTILLE / ORAL826 mgExact identifier — unii candidate
21 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRAMUSCULAR10 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBCAPSULE / ORAL7 mgExact identifier — unii candidate
148 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGRANULE, FOR SUSPENSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSUSPENSION/ DROPS / ORAL4 mgExact identifier — unii candidate
77 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARYADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION / INFILTRATION0.37 %w/vExact identifier — unii candidate
148 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, EXTENDED RELEASE / ORAL1246 mgExact identifier — unii candidate
28 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSPONGE / TOPICALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBINJECTION, SUSPENSION / INTRASYNOVIALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, ORALLY DISINTEGRATING / ORAL3 mgExact identifier — unii candidate
77 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020468-002NASACORT ALLERGY 24 HOURTRIAMCINOLONE ACETONIDE0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11c2088c7a36db…
2026-09-14 22:38:342026-08N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-1184e616aacf4f…
2026-08-18 06:07:402026-07N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-1187673890dc5c…
2021-03-12 10:30 UTC2021-03N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-115aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-118869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-113f01610625f2…
2019-09-15 20:21 UTC2019-09N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11b00525d2431f…
2019-07-19 19:46 UTC2019-07N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-113f0d92c62455…
2023-05-13 08:27 UTC2023-05N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-11053a50430f4f…
2023-01-26 05:58 UTC2023-01N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020468-002NASACORT ALLERGY 24 HOUR0.055MG/SPRAYSPRAY, METERED / NASALRLD, RS2013-10-113a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8028c27c-71a2-4f58-afb0-5948d92dadbf2683ce6a-c4d2-4d51-9bb6-d842581ebdd82022-07-29WarningsExact identifier
spl set id: 2683ce6a-c4d2-4d51-9bb6-d842581ebdd8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.